Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9101592 | POHL BOSKAMP | Stabilized granules containing glyceryl trinitrate |
Mar, 2032
(7 years from now) |
Drugs and Companies using NITROGLYCERIN ingredient
Market Authorisation Date: 08 June, 2016
Treatment: NA
Dosage: POWDER;SUBLINGUAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7872049 | POHL BOSKAMP | Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate |
Mar, 2029
(4 years from now) |
Drugs and Companies using NITROGLYCERIN ingredient
Market Authorisation Date: 31 October, 1985
Treatment: Method of treating angina pectoris
Dosage: SPRAY, METERED;SUBLINGUAL